Source: Health Canada shortage reports · Updated Jul 21, 2026
Some Trandolapril products are in shortage in Canada (4 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 5, 2027.
An ACE inhibitor used to lower blood pressure and protect the heart after a heart attack.
Products affected
4 / 22
In shortage since
Mar 2, 2026
Est. full return
Mar 5, 2027
Reports on file
60
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TRANDOLAPRIL
1MG · CAPSULE · PRO DOC LIMITEE
DIN 02488698 · since Jul 18, 2026, est. end Oct 31, 2026 · Delay in shipping of the drug.
Active shortage
SANDOZ TRANDOLAPRIL
2MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02325756 · since Jul 6, 2026, est. end Mar 5, 2027 · Disruption of the manufacture of the drug.
Active shortage
TRANDOLAPRIL
2MG · CAPSULE · PRO DOC LIMITEE
DIN 02488701 · since Jun 30, 2026, est. end Oct 1, 2026 · Delay in shipping of the drug.
Active shortage
SANDOZ TRANDOLAPRIL
4MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02325764 · since Mar 2, 2026, est. end Oct 2, 2026 · Disruption of the manufacture of the drug.
Anticipated
SANDOZ TRANDOLAPRIL
1MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02325748 · Disruption of the manufacture of the drug.
Anticipated
SANDOZ TRANDOLAPRIL
0.5MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02325721 · Disruption of the manufacture of the drug.
Resolved
MAVIK
2MG · CAPSULE · BGP PHARMA ULC
DIN 02231460 · ended Apr 29, 2026 · Disruption of the manufacture of the drug.
Resolved
MAVIK
0.5MG · CAPSULE · BGP PHARMA ULC
DIN 02231457 · ended Apr 24, 2026 · Disruption of the manufacture of the drug.
Resolved
TRANDOLAPRIL
1MG · CAPSULE · PRO DOC LIMITEE
DIN 02488698 · ended Jan 21, 2026 · Delay in shipping of the drug.
Resolved
PMS-TRANDOLAPRIL
4MG · CAPSULE · PHARMASCIENCE INC
DIN 02357798 · ended Jan 26, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TRANDOLAPRIL
0.5MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02325721 · ended Jan 23, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
MAVIK
1MG · CAPSULE · BGP PHARMA ULC
DIN 02231459 · ended Oct 10, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Trandolapril is currently affected by 4 active shortage reports filed with Health Canada by PRO DOC LIMITEE, SANDOZ CANADA INCORPORATED.
The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Trandolapril is classified under “ACE INHIBITORS, PLAIN” (ATC C09AA).
Recent changes
Jul 21, 2026
New report filed
Jul 13, 2026
New report filed
Jul 13, 2026
New report filed
Common questions
What is Trandolapril used for?
An ACE inhibitor used to lower blood pressure and protect the heart after a heart attack.
When will Trandolapril be back in stock in Canada?
The latest manufacturer estimate is Mar 5, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Trandolapril in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.